TCM
BPMC
Tekla Capital Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-67,710
| Closed | -$3.05M | – | 172 |
|
|
2023
Q1 | $3.05M | Hold |
67,710
| – | – | 0.12% | 98 |
|
|
2022
Q4 | $2.97M | Buy |
+67,710
| New | +$2.97M | 0.11% | 102 |
|
|
2022
Q3 | – | Sell |
-111,118
| Closed | -$5.61M | – | 172 |
|
|
2022
Q2 | $5.61M | Buy |
111,118
+13,865
| +14% | +$700K | 0.22% | 84 |
|
|
2022
Q1 | $6.21M | Buy |
+97,253
| New | +$6.21M | 0.22% | 86 |
|
|
2021
Q3 | – | Sell |
-122,699
| Closed | -$10.8M | – | 177 |
|
|
2021
Q2 | $10.8M | Hold |
122,699
| – | – | 0.35% | 78 |
|
|
2021
Q1 | $11.9M | Hold |
122,699
| – | – | 0.41% | 63 |
|
|
2020
Q4 | $13.8M | Sell |
122,699
-47,319
| -28% | -$5.31M | 0.48% | 58 |
|
|
2020
Q3 | $15.8M | Buy |
170,018
+51,762
| +44% | +$4.8M | 0.59% | 43 |
|
|
2020
Q2 | $9.22M | Sell |
118,256
-21,080
| -15% | -$1.64M | 0.35% | 59 |
|
|
2020
Q1 | $8.15M | Buy |
139,336
+22,411
| +19% | +$1.31M | 0.37% | 51 |
|
|
2019
Q4 | $9.37M | Buy |
116,925
+16,009
| +16% | +$1.28M | 0.35% | 65 |
|
|
2019
Q3 | $7.41M | Buy |
100,916
+5,940
| +6% | +$436K | 0.32% | 64 |
|
|
2019
Q2 | $8.96M | Sell |
94,976
-20,744
| -18% | -$1.96M | 0.37% | 62 |
|
|
2019
Q1 | $9.26M | Sell |
115,720
-9,487
| -8% | -$759K | 0.38% | 57 |
|
|
2018
Q4 | $6.75M | Sell |
125,207
-20,794
| -14% | -$1.12M | 0.29% | 68 |
|
|
2018
Q3 | $11.4M | Hold |
146,001
| – | – | 0.41% | 55 |
|
|
2018
Q2 | $9.27M | Buy |
146,001
+71,780
| +97% | +$4.56M | 0.35% | 65 |
|
|
2018
Q1 | $6.81M | Buy |
+74,221
| New | +$6.81M | 0.26% | 82 |
|